<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7031735\results\search\disease\results.xml">
  <result pre="Respiratory tract infections Virus Abbreviations ARI, acute respiratory illness COPD," exact="chronic obstructive pulmonary disease" post="GSLS, ginseng stem–leaf saponins HRV, human rhinovirus IFN, interferon"/>
  <result pre="occur most commonly in the fall and winter include the" exact="common cold," post="influenza, chronic obstructive pulmonary disease (COPD), asthma, and pneumonia."/>
  <result pre="in the fall and winter include the common cold, influenza," exact="chronic obstructive pulmonary disease" post="(COPD), asthma, and pneumonia. Because of the atypical presentations"/>
  <result pre="(COPD), asthma, and pneumonia. Because of the atypical presentations of" exact="influenza" post="infections, which make effective control difficult, a self-healing approach"/>
  <result pre="difficult, a self-healing approach is taken for the management of" exact="common cold" post="[8]. However, seasonal prophylactic treatment with antiviral drugs and"/>
  <result pre="changes, and response to treatment can help differentiate viral from" exact="bacterial pneumonia" post="[26]; however, detection of a virus in the specimen"/>
  <result pre="and response to treatment can help differentiate viral from bacterial" exact="pneumonia" post="[26]; however, detection of a virus in the specimen"/>
  <result pre="human respiratory pathogen and the main causative agent of seasonal" exact="influenza" post="[44], which is a serious respiratory disease estimated to"/>
  <result pre="causative agent of seasonal influenza [44], which is a serious" exact="respiratory disease" post="estimated to cause around three to five million cases"/>
  <result pre="Influenza has three main types, A, B, and C, with" exact="influenza" post="A being the most virulent in humans, other mammals,"/>
  <result pre="of Red Ginseng extract (RGE) and its purified components on" exact="influenza" post="A infection both in vivo and in vitroas shown"/>
  <result pre="[PD], compound K, and Rh2) showed antiviral activity against several" exact="influenza" post="subtypes (H1N1, H3N2, H5N1, H7N9) in mouse models [48]."/>
  <result pre="RGE and saponin was effective in alleviating the symptoms of" exact="influenza" post="viral infection. Intranasal coadministration of Korean RGE (200 mg/kg"/>
  <result pre="coadministration of Korean RGE (200 mg/kg body weight) with inactivated" exact="influenza" post="virus A (PR8) increased the specific antibody levels in"/>
  <result pre="extracts, saponin fractions, or phosphate-buffered saline for 14 d before" exact="influenza" post="A challenge had a 78%, 67%, 56%, and 17%"/>
  <result pre="as a mucosal adjuvant also played a protective role against" exact="influenza" post="virus A/PR8 viral infection https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052424/ [51]. Table 1 Effect"/>
  <result pre="polysaccharide fraction. [50] P. ginseng aqueous extract powdered capsules Inactivated" exact="influenza" post="virus A PR8 (25 mg) Female inbred BALB/c mice"/>
  <result pre="inducing protective immunity. [51] Ginsenoside Re + inactivated H3N2 Inactivated" exact="influenza" post="virus (H3N2) Female ICR mice 25, 50, or 100"/>
  <result pre="IL-6, but higher levels of IFN-γ [58] RGE HP H5N1" exact="influenza" post="virus Female mice 50 mg/kg body weight) for up"/>
  <result pre="iIELs. Improved systemic and mucosal specific antibody responses [63] RGE" exact="influenza" post="A H1N1 (A/PR8) and A/WSN/1933 viruses BALB/c mice 25"/>
  <result pre="by oral route for 30 days (500 μg/mL) RGE reduced" exact="influenza" post="A virus-induced CPE formation and blocked the induction of"/>
  <result pre="influenza A virus-induced CPE formation and blocked the induction of" exact="influenza" post="A virus pro-inflammatory gene expression. Anti-oxidative and immunomodulatory effects"/>
  <result pre="responses via antibody production, inhibiting the invasion and replication of" exact="influenza" post="virus and aiding the detachment of the virus from"/>
  <result pre="of ginsenoside Re (25, 50, or 100 μg) with inactivated" exact="influenza" post="virus (H3N2) antigen equivalent to 10 or 100 ng"/>
  <result pre="[53]. In addition, immunized mice presented with higher levels of" exact="influenza" post="virus–specific antibodies with amplified neutralizing activities in mucosal secretions"/>
  <result pre="anti-influenza A serum IgG titers with enhanced survival rates after" exact="influenza" post="A infection in mice. Mice receiving RG saponin and"/>
  <result pre="mg/kg), with vaccination before infection, provided enhanced cross-protection against swine-origin" exact="influenza" post="A viruses, including H1N1, antigenically distinct H1N1 subtype A/PR/8/34,"/>
  <result pre="administration (25 mg/kg) intranasally (i.n.) to mice 6 h before" exact="influenza" post="infection exerted a protective effect in the lungs, as"/>
  <result pre="immune response after administration of a bivalent inactive vaccine of" exact="avian influenza" post="in chickens was examined. Data showed that the spleen"/>
  <result pre="response after administration of a bivalent inactive vaccine of avian" exact="influenza" post="in chickens was examined. Data showed that the spleen"/>
  <result pre="RTIs [65,66], generally exhibiting acute and indistinct symptoms, including bronchiolitis," exact="common cold," post="and pneumonia, in infants and immunocompromised patients https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052424/ [67]."/>
  <result pre="the most significant etiological agents of upper respiratory illnesses, particularly" exact="common cold." post="Although mild to indistinguishable, HRV infection can lead to"/>
  <result pre="can lead to severe health complications and severe exacerbation of" exact="asthma" post="[82]. When the antiviral activities of PT-type ginsenosides (Re,"/>
  <result pre="virus-infected cells [83]. Intranasal coadministration of 25 mg of inactivated" exact="influenza" post="A PR8 and ginseng aqueous extract (200 mg/kg) in"/>
  <result pre="[85]]. Biofilm-associated chronic P. aeruginosa lung infections in patients with" exact="cystic fibrosis" post="are difficult to manage with antibiotics due to the"/>
  <result pre="14 d in a rat model of chronic P. aeruginosa" exact="pneumonia" post="mimicking cystic fibrosis significantly increased polymorphonuclear leukocyte chemiluminescence and"/>
  <result pre="in a rat model of chronic P. aeruginosa pneumonia mimicking" exact="cystic fibrosis" post="significantly increased polymorphonuclear leukocyte chemiluminescence and serum IgG2a levels"/>
  <result pre="that P. ginseng could be a useful adjunct therapy in" exact="cystic fibrosis" post="able to alleviate bacterial infections and reduce biofilm formation."/>
  <result pre="innate immune systems [94,95]. Ginseng efficacy in the treatment of" exact="common cold," post="flu, and upper and lower RTIs has been investigated"/>
  <result pre="for a period of 4 months after one month of" exact="influenza" post="vaccine. Evidence indicates that COLD-fX significantly increased lymphocyte proliferation"/>
  <result pre="55% and 48%, respectively in immunocompromised aged patients during the" exact="influenza" post="season [97]. COLD-fX, as a seasonal prophylactic was evaluated"/>
  <result pre="up the pathogenic heat. Wake Forest University, USANCT00752895 ARI +" exact="chronic lymphocytic leukemia" post="(CLL) (≥18 years) N = 293 COLD-fX Oral extract"/>
  <result pre="pathogenic heat. Wake Forest University, USANCT00752895 ARI + chronic lymphocytic" exact="leukemia" post="(CLL) (≥18 years) N = 293 COLD-fX Oral extract"/>
  <result pre="in the G115 group and is able to protect against" exact="common cold" post="and influenza. [110] Republic of KoreaNCT01478009 Acute Respiratory Illness"/>
  <result pre="[112] ARI, acute respiratory illness; CHM, Chinese herbal medicine; COPD," exact="chronic obstructive pulmonary disease;" post="LCCUs, laboratory-confirmed clinical upper respiratory infections; LCII, laboratory-confirmed influenza"/>
  <result pre="pulmonary disease; LCCUs, laboratory-confirmed clinical upper respiratory infections; LCII, laboratory-confirmed" exact="influenza" post="illness; NCT, clinical trial number; URTI, upper respiratory tract"/>
  <result pre="the incidence rate of acute respiratory illness (ARI) during the" exact="influenza" post="season. Data obtained for laboratory-confirmed influenza and RSV infections"/>
  <result pre="illness (ARI) during the influenza season. Data obtained for laboratory-confirmed" exact="influenza" post="and RSV infections showed that COLD-fX was safe and"/>
  <result pre="ARI or antibiotic use in patients with ARI infected with" exact="chronic lymphocytic leukemia" post="[109]. Antibody titers and natural killer cell activities in"/>
  <result pre="antibiotic use in patients with ARI infected with chronic lymphocytic" exact="leukemia" post="[109]. Antibody titers and natural killer cell activities in"/>
  <result pre="WHO/Europe projectInt J Public Health605201561962726024815 2MartinoD.PrescottS.Epigenetics and prenatal influences on" exact="asthma" post="and allergic airways diseaseChest1393201164064721362650 3SchwelaD.Air pollution and health in"/>
  <result pre="pollution and respiratory infectionsPaediatr Respir Rev152201419419924704510 8HeikkinenT.JarvinenA.The common coldLancet36193512003515912517470 9NicholK.L.Improving" exact="influenza" post="vaccination rates among adultsCleve Clin J Med731120061009101517128542 10ChapmanK.R.ManninoD.M.SorianoJ.B.VermeireP.A.BuistA.S.ThunM.J.ConnellC.JemalA.LeeT.A.MiravitllesM.Epidemiology and"/>
  <result pre="plan: Australian and New Zealand guidelines for the management of" exact="chronic obstructive pulmonary disease" post="20092009https://pdfs.semanticscholar.org/f4d3/23c5e688345b42916dc4b279fd2d6a598e9b.pdf 16HolgateS.T.PolosaR.Treatment strategies for allergy and asthmaNat Rev Immunol83200821823018274559"/>
  <result pre="management of chronic obstructive pulmonary disease 20092009https://pdfs.semanticscholar.org/f4d3/23c5e688345b42916dc4b279fd2d6a598e9b.pdf 16HolgateS.T.PolosaR.Treatment strategies for" exact="allergy" post="and asthmaNat Rev Immunol83200821823018274559 17LynchJ.P.ZhanelG.G.Streptococcus pneumoniae: epidemiology, risk factors,"/>
  <result pre="factors, and strategies for preventionSemin Respir Crit Care Med302200918920919296419 18FonkwoP.N.Pricing" exact="infectious disease." post="The economic and health implications of infectious diseasesEMBO Rep9Suppl"/>
  <result pre="a Systematic Review and Meta-analysisHosp Pediatr56201532433626034164 22MartinN.G.SadaranganiM.PollardA.J.GoldacreM.J.Hospital admission rates for" exact="meningitis" post="and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and"/>
  <result pre="America/American Thoracic Society consensus guidelines on the management of community-acquired" exact="pneumonia" post="in adultsClin Infect Dis44Suppl 22007S27S7217278083 25MiyashitaN.SaitoA.KohnoS.YamaguchiK.WatanabeA.OdaH.KazuyamaY.MatsushimaT.collab: CAP Study GroupMultiplex"/>
  <result pre="pigs to porcine parvovirus and Erysipelothrix rhusiopathiaeVet Immunol Immunopathol9112003192712507846 44NeumannG.ChenH.GaoG.F.ShuY.KawaokaY.H5N1" exact="influenza" post="viruses: outbreaks and biological propertiesCell Res2012010516119884910 45World Health OrganizationFact"/>
  <result pre="outbreaks and biological propertiesCell Res2012010516119884910 45World Health OrganizationFact sheets 211" exact="influenza" post="(seasonal) [Internet] Geneva2016World Health OrganizationAvailable from:http://www.who.int/mediacentre/factsheets/fs211/en 46FarooquiA.LeiY.WangP.HuangJ.LinJ.LiG.LeonA.J.ZhaoZ.KelvinD.J.Genetic and clinical"/>
  <result pre="Health OrganizationAvailable from:http://www.who.int/mediacentre/factsheets/fs211/en 46FarooquiA.LeiY.WangP.HuangJ.LinJ.LiG.LeonA.J.ZhaoZ.KelvinD.J.Genetic and clinical assessment of 2009 pandemic" exact="influenza" post="in southern ChinaJ Infect Dev Ctries510201170071021997938 47DongW.FarooquiA.LeonA.J.KelvinD.J.Inhibition of influenza"/>
  <result pre="pandemic influenza in southern ChinaJ Infect Dev Ctries510201170071021997938 47DongW.FarooquiA.LeonA.J.KelvinD.J.Inhibition of" exact="influenza" post="A virus infection by ginsenosidesPLoS One1222017e0171936 48WangY.JungY.J.KimK.H.KwonY.KimY.J.ZhangZ.KangH.S.WangB.Z.QuanF.S.KangS.M.Antiviral activity of"/>
  <result pre="activity of fermented ginseng Extracts against a broad range of" exact="influenza" post="virusesViruses1092018E471 49ChanL.Y.KwokH.H.ChanR.W.PeirisM.J.MakN.K.WongR.N.ChanM.C.YueP.Y.Dual functions of ginsenosides in protecting human endothelial"/>
  <result pre="49ChanL.Y.KwokH.H.ChanR.W.PeirisM.J.MakN.K.WongR.N.ChanM.C.YueP.Y.Dual functions of ginsenosides in protecting human endothelial cells against" exact="influenza" post="H9N2-induced inflammation and apoptosisJ Ethnopharmacol137320111542154621872652 50YinS.Y.KimH.J.KimH.J.A comparative study of"/>
  <result pre="whole red ginseng extract and polysaccharide and saponin fractions on" exact="influenza" post="A (H1N1) virus infectionBiol Pharm Bull36620131002100723727921 51QuanF.S.CompansR.W.ChoY.K.KangS.M.Ginseng and Salviae"/>
  <result pre="a role as immune activators and modulate immune responses during" exact="influenza" post="virus infectionVaccine252200727228216945454 52WuH.HoibyN.YangL.GivskovM.SongZ.Effects of radix ginseng on microbial infections:"/>
  <result pre="narrative reviewJ Tradit Chin Med342201422723324783938 53SongX.ChenJ.SakwiwatkulK.LiR.HuS.Enhancement of immune responses to" exact="influenza" post="vaccine (H3N2) by ginsenoside ReInt Immunopharmacol103201035135620034596 54RitchieA.I.FarneH.A.SinganayagamA.JacksonD.J.MalliaP.JohnstonS.L.Pathogenesis of viral"/>
  <result pre="and saponin enhances the protection conferred by vaccination with inactivated" exact="influenza" post="a virusJ Ginseng Res364201239640223717142 57SchwarzeJ.MackenzieK.J.Novel insights into immune and"/>
  <result pre="red ginseng extract on the infections by H1N1 and H3N2" exact="influenza" post="viruses in miceJ Med Food1510201285586222856395 59ParkE.H.YumJ.KuK.B.KimH.M.KangY.M.KimJ.C.KimJ.A.KangY.K.SeoS.H.Red Ginseng-containing diet helps"/>
  <result pre="and ferrets from the lethal infection by highly pathogenic H5N1" exact="influenza" post="virusJ Ginseng Res3812014404624558309 60YooD.G.KimM.C.ParkM.K.ParkK.M.QuanF.S.SongJ.M.WeeJ.J.WangB.Z.ChoY.K.CompansR.W.Protective effect of ginseng polysaccharides on"/>
  <result pre="influenza virusJ Ginseng Res3812014404624558309 60YooD.G.KimM.C.ParkM.K.ParkK.M.QuanF.S.SongJ.M.WeeJ.J.WangB.Z.ChoY.K.CompansR.W.Protective effect of ginseng polysaccharides on" exact="influenza" post="viral infectionPLoS One732012e33678 61ZhaiL.LiY.WangW.HuS.Enhancement of humoral immune responses to"/>
  <result pre="61ZhaiL.LiY.WangW.HuS.Enhancement of humoral immune responses to inactivated Newcastle disease and" exact="avian influenza" post="vaccines by oral administration of ginseng stem-and-leaf saponins in"/>
  <result pre="of humoral immune responses to inactivated Newcastle disease and avian" exact="influenza" post="vaccines by oral administration of ginseng stem-and-leaf saponins in"/>
  <result pre="immune responses to a bivalent vaccine of Newcastle disease and" exact="avian influenza" post="in chickens by ginseng stem-leaf saponinsVet Immunol Immunopathol1673–4201514715526277227 64GrahamB.S.Biological"/>
  <result pre="responses to a bivalent vaccine of Newcastle disease and avian" exact="influenza" post="in chickens by ginseng stem-leaf saponinsVet Immunol Immunopathol1673–4201514715526277227 64GrahamB.S.Biological"/>
  <result pre="cotton ratsJ Infect Dis1851220021780178512085325 72LeeJ.S.HwangH.S.KoE.J.LeeY.N.KwonY.M.KimM.C.KangS.M.Immunomodulatory activity of red ginseng against" exact="influenza" post="A virus infectionNutrients62201451752924473234 73LeeJ.S.ChoM.K.HwangH.S.KoE.J.LeeY.N.KwonY.M.KimM.C.KimK.H.LeeY.T.JungY.J.Ginseng diminishes lung disease in mice"/>
  <result pre="of red ginseng against influenza A virus infectionNutrients62201451752924473234 73LeeJ.S.ChoM.K.HwangH.S.KoE.J.LeeY.N.KwonY.M.KimM.C.KimK.H.LeeY.T.JungY.J.Ginseng diminishes" exact="lung disease" post="in mice immunized with formalin-inactivated respiratory syncytial virus after"/>
  <result pre="and Asian ginseng (Panax ginseng) preparations for prevention of the" exact="common cold" post="in healthy adults: a systematic reviewEvid Based Complement Alternat"/>
  <result pre="schedulesPediatrics12222008e402e41018676527 103XueC.C.ShergisJ.L.ZhangA.L.WorsnopC.FongH.StoryD.Da CostaC.ThienF.C.Panax ginseng C.A Meyer root extract for moderate" exact="chronic obstructive pulmonary disease" post="(COPD): study protocol for a randomised controlled trialTrials12201116421718484 104WuL.ZhangA.L.DiY.M.ShergisJ.L.ChenY.GuoX.WenZ.ThienF.WorsnopC.LinL.Panax"/>
  <result pre="the standardised ginseng extract G115 for potentiating vaccination against the" exact="influenza" post="syndrome and protection against the common cold [corrected]Drugs Exp"/>
  <result pre="potentiating vaccination against the influenza syndrome and protection against the" exact="common cold" post="[corrected]Drugs Exp Clin Res222199665728879982 111LeeC.S.LeeJ.H.OhM.ChoiK.M.JeongM.R.ParkJ.D.KwonD.Y.HaK.C.ParkE.O.LeeN.Preventive effect of Korean red"/>
 </snippets>
</snippetsTree>
